HRMY
Price
$32.07
Change
-$0.35 (-1.08%)
Updated
Sep 23 closing price
Capitalization
1.85B
41 days until earnings call
LGND
Price
$170.65
Change
-$0.12 (-0.07%)
Updated
Sep 23 closing price
Capitalization
3.33B
42 days until earnings call
Interact to see
Advertisement

HRMY vs LGND

Header iconHRMY vs LGND Comparison
Open Charts HRMY vs LGNDBanner chart's image
Harmony Biosciences Holdings
Price$32.07
Change-$0.35 (-1.08%)
Volume$524.78K
Capitalization1.85B
Ligand Pharmaceuticals
Price$170.65
Change-$0.12 (-0.07%)
Volume$133.77K
Capitalization3.33B
HRMY vs LGND Comparison Chart in %
Loading...
HRMY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
LGND
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
HRMY vs. LGND commentary
Sep 24, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is HRMY is a StrongBuy and LGND is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Sep 24, 2025
Stock price -- (HRMY: $32.07 vs. LGND: $170.65)
Brand notoriety: HRMY and LGND are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: HRMY: 79% vs. LGND: 52%
Market capitalization -- HRMY: $1.85B vs. LGND: $3.33B
HRMY [@Biotechnology] is valued at $1.85B. LGND’s [@Biotechnology] market capitalization is $3.33B. The market cap for tickers in the [@Biotechnology] industry ranges from $97.36B to $0. The average market capitalization across the [@Biotechnology] industry is $1.91B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

HRMY’s FA Score shows that 0 FA rating(s) are green whileLGND’s FA Score has 0 green FA rating(s).

  • HRMY’s FA Score: 0 green, 5 red.
  • LGND’s FA Score: 0 green, 5 red.
According to our system of comparison, HRMY is a better buy in the long-term than LGND.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

HRMY’s TA Score shows that 5 TA indicator(s) are bullish while LGND’s TA Score has 3 bullish TA indicator(s).

  • HRMY’s TA Score: 5 bullish, 5 bearish.
  • LGND’s TA Score: 3 bullish, 5 bearish.
According to our system of comparison, HRMY is a better buy in the short-term than LGND.

Price Growth

HRMY (@Biotechnology) experienced а -0.68% price change this week, while LGND (@Biotechnology) price change was +2.65% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +2.75%. For the same industry, the average monthly price growth was +7.78%, and the average quarterly price growth was +47.65%.

Reported Earning Dates

HRMY is expected to report earnings on Nov 04, 2025.

LGND is expected to report earnings on Nov 05, 2025.

Industries' Descriptions

@Biotechnology (+2.75% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
LGND($3.33B) has a higher market cap than HRMY($1.85B). LGND has higher P/E ratio than HRMY: LGND (46.19) vs HRMY (10.35). LGND YTD gains are higher at: 59.263 vs. HRMY (-6.800). HRMY has higher annual earnings (EBITDA): 265M vs. LGND (-45.94M). HRMY has more cash in the bank: 565M vs. LGND (255M). LGND has less debt than HRMY: LGND (5.74M) vs HRMY (172M). HRMY has higher revenues than LGND: HRMY (773M) vs LGND (188M).
HRMYLGNDHRMY / LGND
Capitalization1.85B3.33B55%
EBITDA265M-45.94M-577%
Gain YTD-6.80059.263-11%
P/E Ratio10.3546.1922%
Revenue773M188M411%
Total Cash565M255M222%
Total Debt172M5.74M2,995%
FUNDAMENTALS RATINGS
LGND: Fundamental Ratings
LGND
OUTLOOK RATING
1..100
64
VALUATION
overvalued / fair valued / undervalued
1..100
73
Overvalued
PROFIT vs RISK RATING
1..100
39
SMR RATING
1..100
95
PRICE GROWTH RATING
1..100
39
P/E GROWTH RATING
1..100
90
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
HRMYLGND
RSI
ODDS (%)
Bullish Trend 1 day ago
90%
Bearish Trend 1 day ago
65%
Stochastic
ODDS (%)
Bullish Trend 1 day ago
75%
Bearish Trend 1 day ago
68%
Momentum
ODDS (%)
Bearish Trend 1 day ago
80%
Bullish Trend 1 day ago
77%
MACD
ODDS (%)
Bearish Trend 1 day ago
71%
Bearish Trend 1 day ago
70%
TrendWeek
ODDS (%)
Bearish Trend 1 day ago
75%
Bullish Trend 1 day ago
75%
TrendMonth
ODDS (%)
Bearish Trend 1 day ago
74%
Bullish Trend 1 day ago
76%
Advances
ODDS (%)
Bullish Trend 21 days ago
76%
Bullish Trend 13 days ago
75%
Declines
ODDS (%)
Bearish Trend 1 day ago
76%
Bearish Trend 9 days ago
73%
BollingerBands
ODDS (%)
Bullish Trend 1 day ago
84%
Bearish Trend 1 day ago
66%
Aroon
ODDS (%)
Bullish Trend 1 day ago
74%
Bullish Trend 1 day ago
81%
View a ticker or compare two or three
Interact to see
Advertisement
HRMY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
LGND
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
RREAX29.580.15
+0.51%
Russell Inv Global Real Estate Secs A
STREX22.21N/A
N/A
Sterling Capital Equity Income R6
JSEQX53.27-0.20
-0.37%
JPMorgan Small Cap Equity R4
FNEFX75.36-0.42
-0.55%
American Funds New Economy F3
ETIEX14.80-0.12
-0.80%
Eventide Exponential Technologies I

LGND and

Correlation & Price change

A.I.dvisor indicates that over the last year, LGND has been loosely correlated with AGIO. These tickers have moved in lockstep 49% of the time. This A.I.-generated data suggests there is some statistical probability that if LGND jumps, then AGIO could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To LGND
1D Price
Change %
LGND100%
-0.07%
AGIO - LGND
49%
Loosely correlated
-0.84%
CRSP - LGND
47%
Loosely correlated
-2.16%
SYRE - LGND
47%
Loosely correlated
+4.77%
ACLX - LGND
45%
Loosely correlated
+1.19%
OCUL - LGND
44%
Loosely correlated
+0.41%
More